Confidential
Head of Clinical Development
About the Company
Excelling biotechnology (BioTech) company
Industry Biotechnology
Type Privately Held
About the Role
The Company is in search of a Head of Clinical Development (S/VP) to spearhead the clinical and regulatory strategy for its pioneering pipeline of antibody drug conjugates in cancer therapeutics. The successful candidate will be responsible for defining and overseeing the clinical development strategy, leading IND, CTA, and regulatory filings, and directing Phase I-III clinical trials to ensure scientific and operational excellence. This role also involves close collaboration with R&D and translational medicine teams to optimize biomarker-driven trial design, as well as representing the company at various industry events. The Head of Clinical Development will play a key role in partnering with BD and commercial teams on strategic partnerships and future market planning.
Applicants for the Head of Clinical Development position at the company should hold an MD or MD/PhD with a minimum of 10 years' experience in clinical development, particularly in the field of oncology. The ideal candidate will have a strong background in oncology drug development, including experience with bispecifics, T-cell engagers, and immune modulators, and a proven track record of advancing oncology assets from early-phase trials through regulatory approval. Extensive experience in regulatory interactions with FDA and EMA, as well as global trial execution, is essential. The role requires a leader who can thrive in a VC-backed, high-growth biotech environment and is adept at driving the development of cutting-edge therapies from IND through regulatory approval.
Travel Percent Less than 10%
Functions
Medical Care/Hospital Administration Strategy
About the Company
Excelling biotechnology (BioTech) company
Industry Biotechnology
Type Privately Held
About the Role
The Company is in search of a Head of Clinical Development (S/VP) to spearhead the clinical and regulatory strategy for its pioneering pipeline of antibody drug conjugates in cancer therapeutics. The successful candidate will be responsible for defining and overseeing the clinical development strategy, leading IND, CTA, and regulatory filings, and directing Phase I-III clinical trials to ensure scientific and operational excellence. This role also involves close collaboration with R&D and translational medicine teams to optimize biomarker-driven trial design, as well as representing the company at various industry events. The Head of Clinical Development will play a key role in partnering with BD and commercial teams on strategic partnerships and future market planning.
Applicants for the Head of Clinical Development position at the company should hold an MD or MD/PhD with a minimum of 10 years' experience in clinical development, particularly in the field of oncology. The ideal candidate will have a strong background in oncology drug development, including experience with bispecifics, T-cell engagers, and immune modulators, and a proven track record of advancing oncology assets from early-phase trials through regulatory approval. Extensive experience in regulatory interactions with FDA and EMA, as well as global trial execution, is essential. The role requires a leader who can thrive in a VC-backed, high-growth biotech environment and is adept at driving the development of cutting-edge therapies from IND through regulatory approval.
Travel Percent Less than 10%
Functions
Medical Care/Hospital Administration Strategy